In contrast to the finding that Endo180 is uncoupled from its ability to promote tumor cell migration on compliant (non-crosslinked) fibroblast-derived ECM, no differences were observed in the migration of tumor cells on non-crosslinked versus crosslinked osteoblast-derived ECM. The gene discussed is MRC2; the disease is neoplasm.